9th Jul 2008 07:00
9 July 2008
SYNERGY HEALTHCARE PLC
("Synergy", "the Company" or "the Group")
Trading Update
Synergy Healthcare plc (SYR.L), a leading international provider of sterilisation and infection control solutions for hospitals and the healthcare industry, is today hosting a meeting with its senior executive board giving an opportunity for shareholders and analysts to meet the senior operational management team. At the meeting the following update on trading will be given:
Sales during the first quarter of the year have met expectations with group sales up approximately 30%. All of our divisions have continued to perform in line with the trends set in the previous year.
We are also pleased to announce that the Central Lancashire National Decontamination Scheme has reached financial close. Services under this scheme will begin in the autumn with full service transfer completing within 12 months.
The Group has also been awarded a further four sterilisation contracts worth approximately £0.9 million p.a., adding a further £3.4 million to the Surgical order book.
Further updates will be provided at the Company's AGM on Thursday 24 July.
|
For further information: |
|
|
Synergy Healthcare plc Dr Richard Steeves, Chief Executive Ivan Jacques, Finance Director |
01793 891851 |
|
Investec Patrick Robb |
020 7597 5169 |
|
Morgan Stanley Peter Moorhouse Jon Bathard-Smith |
020 7677 4056 |
|
Financial Dynamics David Yates / Ben Brewerton Emma Thompson |
020 7831 3113 |
Related Shares:
SYR.L